Bopindolol-d9

• Description:

  Bopindolol-d9 ((±) -Bopindolol-d9) is the deuterium labeled Bopindolol (HY-B1562) . Bopindolol ((±) -Bopindolol) is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol has intrinsic sympathomimetic as well as membrane stabilizing actions, inhibits renin secretion, and interacts with 5-HT receptors. Bopindolol is a proagent of Pindolol (HY-B0982) . Bopindolol can be used for essential and renovascular hypertension research.

• Product Name Alternative:

  (±) -Bopindolol-d9

• UNSPSC:

  12352005

• Target:

  5-HT Receptor; Adrenergic Receptor; Isotope-Labeled Compounds

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling; Others

• Field of Research:

  Neurological Disease

• Smiles:

  [2H]C([2H])([2H])C(C([2H])([2H])[2H])(C([2H])([2H])[2H])NCC(COC1=CC=CC2=C1C=C(N2)C)OC(=O)C3=CC=CC=C3

• Molecular Formula:

  C23H19D9N2O3

• Molecular Weight:

  389.54

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  [1794891-82-9]